Outlook Therapeutics (OTLK) Accounts Payables: 2015-2019
Historic Accounts Payables for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2019 value amounting to $2.3 million.
- Outlook Therapeutics' Accounts Payables rose 67.66% to $5.0 million in Q2 2020 from the same period last year, while for Jun 2020 it was $5.0 million, marking a year-over-year increase of 67.66%. This contributed to the annual value of $2.3 million for FY2019, which is 36.90% down from last year.
- Latest data reveals that Outlook Therapeutics reported Accounts Payables of $2.3 million as of FY2019, which was down 36.90% from $3.6 million recorded in FY2018.
- Outlook Therapeutics' 5-year Accounts Payables high stood at $11.6 million for FY2015, and its period low was $2.3 million during FY2019.
- In the last 3 years, Outlook Therapeutics' Accounts Payables had a median value of $3.6 million in 2018 and averaged $5.6 million.
- In the last 5 years, Outlook Therapeutics' Accounts Payables surged by 116.00% in 2017 and then tumbled by 67.05% in 2018.
- Yearly analysis of 5 years shows Outlook Therapeutics' Accounts Payables stood at $11.6 million in 2015, then crashed by 56.14% to $5.1 million in 2016, then skyrocketed by 116.00% to $11.0 million in 2017, then tumbled by 67.05% to $3.6 million in 2018, then plummeted by 36.90% to $2.3 million in 2019.